Continuous showed no clear difference in all‐cause mortality compared with intermittent Antibiotic Infusions (moderate certainty).
Continuous showed no clear difference in infection recurrence compared with intermittent Antibiotic Infusions (low certainty).
Continuous showed no clear difference in clinical cure compared with intermittent Antibiotic Infusions (low certainty).
Continuous showed no clear difference in super‐infection compared with intermittent Antibiotic Infusions (low certainty).
Continuous showed no clear difference in serious adverse events compared with intermittent Antibiotic Infusions (low certainty).
Continuous showed no clear difference in withdrawal due to adverse events compared with intermittent Antibiotic Infusions (low certainty).
It is very uncertain whether continuous changes adverse events compared with intermittent Antibiotic Infusions (very low certainty).
Nasal high flow showed no clear difference in BPD (supplemental oxygen/respiratory support at 36 weeks'… compared with nasal intermittent positive pressure ventilation (low certainty).
Nasal high flow showed no clear difference in treatment failure within 72 hours of trial entry compared with nasal intermittent positive pressure ventilation (moderate certainty).
Nasal high flow showed no clear difference in mechanical ventilation within 72 hours of trial entry compared with nasal intermittent positive pressure ventilation (moderate certainty).
Nasal high flow showed no clear difference in pneumothorax (during assigned treatment) compared with nasal intermittent positive pressure ventilation (moderate certainty).
Nasal high flow probably leads to lower nasal trauma (during assigned treatment) compared with nasal intermittent positive pressure ventilation (moderate certainty).
It is very uncertain whether nasal high flow changes death (before hospital discharge) or BPD (supplemental… compared with nasal intermittent positive pressure ventilation (very low certainty).
Nasal high flow showed no clear difference in death (before hospital discharge) compared with nasal intermittent positive pressure ventilation (low certainty).
The review found no eligible studies for this question.
Continuous phenobarbital showed no clear difference in recurrent seizure at 12 months compared with intermittent rectal or oral diazepam (low certainty).
It is very uncertain whether continuous phenobarbital changes recurrent seizure at 18 months compared with intermittent rectal or oral diazepam (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.